This study is in progress, not accepting new patients
PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA
Summary
- Eligibility
- for people ages 18-50 (full criteria)
- Location
- at Irvine, California and other locations
- Dates
- study startestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Pfizer
- Links
- To obtain contact information for a study center near you, click here.
- ID
- NCT04517864
- Phase
- Phase 2 Alopecia Research Study
- Study Type
- Interventional
- Participants
- About 71 people participating
- Last Updated